Binciken sukari ya nuna alamun rashin ingancin rayuwa a cikin 1 cikin marasa lafiya 5

Labarai

Ciwon sukari mellitus shine ɗayan cututtukan yau da kullun a Amurka, a cewar Cibiyoyin Kula da Cututtuka da Cututtuka ( CDC ), kuma yaduwar ciwon suga na karuwa. A cikin 2018, mutane miliyan 34.2 suna da ciwon sukari. Wannan shine 10.5% na yawan jama'ar Amurka. Kudin ciwon sukari kuma yana karuwa. Kimanin kudin likitanci ga kowane mutum da ke fama da ciwon suga ya karu daga $ 8,417 a 2012 zuwa $ 9,601 a 2017.

SingleCare ta bincika mutane 500 da ke fama da ciwon sukari don ƙarin koyo game da yanayin, zaɓuɓɓukan maganinsa, da tasirinsa ga rayuwar Amurkawa da walat.

Dangantaka: Statisticsididdigar ciwon sukari

Takaita abubuwan binciken:

• 1 a cikin 5 da aka amsa sun bayar da rahoton cewa alamun su na rage darajar rayuwarsu gaba ɗaya.
• Reportedlyananan masu amsawa suna fama da mummunar cutar ta ciwon sukari fiye da tsofaffin masu ba da amsa.
• Kusan kashi biyu cikin uku na masu amsa suna da damuwa cewa yanayin su yana da haɗarin kamuwa da COVID-19.
• Mafi yawan nau'ikan shan magungunan sikari a tsakanin masu yin binciken sune manyan mutane kamar metformin.
• Sashin insulin na dogon lokaci shine nau'in insulin gama gari tsakanin masu binciken mu.
• Yin fitsari akai-akai, gajiya, da kuma alamun GI sune rahotanni mafi yawan illolin magunguna masu magunguna ko insulin.
• 54% na masu amsa suna biya daga aljihunsu don kula da ciwon sukari.

1 a cikin 5 da aka amsa sun bayar da rahoton cewa alamun su na rage darajar rayuwarsu gaba ɗaya

A matsayina na rashin lafiya na yau da kullun, ba abin mamaki bane cewa ciwon sukari ya shafi rayuwar yau da kullun ga yawancin marasa lafiyar ciwon sukari. Maganin ciwon suga yawanci yana buƙatar canje-canje na rayuwa mai kyau da magani na yau da kullun, kuma kashi 74% na masu binciken binciken sun ba da rahoton samun ƙarin matsalar ƙwaƙwalwa da / ko lafiyar lafiyar jiki (haɗuwa).

• 48% a gwargwadon rahoto ci mafi koshin lafiya.
  • 25% na waɗanda suka bayar da rahoton sun fi lafiya sun kuma bayar da rahoton cewa ba su da wata matsala ta ciwon sukari ko yanayin rashin lafiya.
• 30% sun bayar da rahoton karin motsa jiki.
  • 24% na waɗanda suka bayar da rahoton ƙarin motsa jiki sun kuma bayar da rahoton cewa ba su da wata matsala ta ciwon sukari ko yanayin comorbid.
• 30% sun bayar da rahoton cewa suna da ƙarancin ƙarfi don yin ayyukan yau da kullun.
• 29% sun bayar da rahoton damuwa game da yanayin su da / ko yiwuwar rikicewar ciwon sukari.
  • 34% na waɗannan masu amsawa suma suna fuskantar tasirin GI (baƙin ciki, gas, gudawa, tashin zuciya, amai), kuma 57% suma sun ba da rahoton samun hauhawar jini.
• 19% sun ruwaito alamun su sun rage ingancin rayuwarsu.
  • Daga cikin waɗannan masu ba da amsa, 13% kuma sun ba da rahoton asarar nauyi, 21% sun ba da rahoton cututtukan yisti, 20% sun ba da rahoton ƙarancin jini, kuma 32% sun ba da rahoton ƙarancin numfashi azaman tasirin magungunan ciwon suga.
  • Daga cikin waɗannan masu ba da amsa, 16% kuma sun ba da rahoton suna da cutar koda kuma 15% kuma sun ba da rahoton cewa suna da cutar hanta mai haɗari.
• 18% an bayar da rahoto game da yanayin su.
• 17% sun ba da rahoton halin da suke ciki ba ya tasiri ga rayuwarsu ta yau da kullun.
  • Fiye da rabi (55%) na waɗannan masu amsa kuma sun bayar da rahoton rashin shan magungunan ciwon sukari ko insulin.
  • Rabin (51%) na waɗannan masu bayar da rahoton sun kuma ba da rahoton cewa ba su fuskantar wata matsala ta ciwon sukari ko yanayin comorbid.
• 16% sun ba da rahoton halin da suke ciki yana hana yarda da kai.
  • Daga cikin wadannan masu bayar da amsar, kashi 45% sun kuma bayar da rahoton suna da hauhawar jini, 17% kuma sun bayar da rahoton suna da hyperlipidemia ko dyslipidemia, 18% kuma sun bayar da rahoton suna da cutar koda, 20% sun bayar da rahoton suna da cutar hanta mai haɗari, 16% kuma sun bayar da rahoton suna da ciwon ƙafa, 15% kuma sun ruwaito da ciwon tarihi na ciwon sukari ketoacidosis.
• 15% sun ba da rahoton tsarin kula da ciwon sukari ya ba su damar rayuwa mafi ƙoshin lafiya.
  • Kusan kashi ɗaya cikin huɗu (21%) na waɗanda aka ba da rahoton suna rayuwa mafi ƙoshin lafiya kuma sun ba da rahoton cewa ba su da wata matsala ta ciwon sukari ko yanayin rashin lafiya.
• 13% sun bayar da rahoton damuwa game da yadda za su iya biyan magungunan ciwon sukari da kayayyaki.
• 8% sun ruwaito halin da suke ciki ya shafi makarantar su ko aikin su.
• 8% sun ba da rahoton halin da suke ciki ya cutar da alaƙar su.
  • Wadannan masu ba da amsa sun kuma bayar da rahoton kasancewar mafi yawan rikitarwa na ciwon sukari ko yanayin comorbid. Daga cikin waɗannan masu ba da amsa, 19% kuma sun ba da rahoton suna da ciwon zuciya, 60% kuma sun ba da rahoton suna da hauhawar jini, 60% kuma sun ba da rahoton suna da nauyi ko kiba, 24% kuma sun ba da rahoton suna da cututtukan zuciya da jijiyoyin jini, 24% kuma sun bayar da rahoton suna da cutar koda, 52% kuma sun bayar da rahoton ciwon rashin gani, kuma kashi 29% sun kuma bayar da rahoton suna da ciwon ulcer.
• 1% sun ruwaito wasu hanyoyi yanayin su yana shafar rayuwar su ta yau da kullun.

Dangantaka: Matakan sikari na jini

Reportedlyananan masu amsawa suna fama da mummunar cutar ta ciwon sukari fiye da tsofaffin masu ba da amsa

Masu ba da amsa mai shekaru ashirin da biyar zuwa 34 sun fi bayar da rahoton mummunan tasirin prediabetis / ciwon sukari a rayuwar yau da kullun.

• 31% na wannan ƙungiyar sun ba da rahoton alamominsu sun rage darajar rayuwarsu.
• 28% na wannan ƙungiyar sun ba da rahoton halin da suke ciki yana hana yarda da kansu.
• 28% na wannan ƙungiyar suna ba da rahoton baƙin ciki game da yanayin su.
• 27% na wannan ƙungiyar an ba da rahoton damuwa game da yanayin su da / ko yiwuwar rikicewar sa.
• 21% na wannan rukunin shekarun sun ba da rahoton halin da suke ciki ya shafi alaƙar su.
• 15% na wannan rukunin shekarun sun ba da rahoton halin da suke ciki ya shafi makarantar su da aikinsu.

A gefe guda kuma, masu amsa tambayoyin masu shekaru 55 zuwa sama sun kasance mafi akasarin yanayin su.

• 52% na masu amsa masu shekaru 55 zuwa 64 da 51% masu shekaru 65 da sama sun ba da rahoton cewa suna cin ƙoshin lafiya.
• 26% na masu amsa masu shekaru 55 zuwa 64 da 23% masu shekaru 65 da haihuwa sun bada rahoton cewa yanayin su baya shafar rayuwar su ta yau da kullun.
• 19% na masu amsa masu shekaru 65 zuwa sama sun ba da rahoton cewa tsarin kula da ciwon sukari ya ba su damar rayuwa mafi ƙoshin lafiya.

Kusan kashi biyu bisa uku na masu amsa suna da damuwa cewa suna cikin haɗarin kamuwa da COVID-19 saboda ciwon sukari

Daga cikin wadanda suka bayar da rahoton wadanda suka damu, kashi 76% daga cikinsu suna da cutar siga ta Type 1. Wannan abin birgewa ne saboda mutanen da ke dauke da ciwon sukari na 2 sun bayyana suna cikin haɗarin kamuwa da cuta mai tsanani daga coronavirus fiye da waɗanda ke da Type 1, a cewar CDC .

• 62% suna damuwa
• 38% ba su damu ba

Mafi yawan nau'ikan shan magungunan sikari a tsakanin masu binciken sune manyan mutane kamar metformin

Kashi na masu yin binciken	Ajin magani	Misalan magunguna a cikin ajin magani
36%	Biguanides	Riomet , Kamfanin Fortamet , Barkwanci , Glucophage ( metformin )
19%	Insulin
10%	Sulfonylureas	Amaryl , DiaBeta, Diabinese, Glucotrol ( nishadi ), Glycron, Glynase , Micronase, Tol-Tab, Tolinase
9%	Abubuwan kirkirar jiki (GLP-1 agonists)	Adlyxin, Bydureon, Byetta ,, Gaskiya , Victoza , Ozempic
7%	Gliptins (DPP-4 masu hanawa)	Januvia , Galvus, Onglyza, Tradjenta, Nesina
6%	Gliflozins (SGLT-2 masu hanawa)	- Steglatro, Farin Ciki , Invokana, Jardiance
5%	Thiazolidinediones (TZDs)	Avandia , Ayyukan Manzanni
4%	Hadin magani	- Invokamet, Janumet , Synjardy
3%	Masu hana Alpha-glucosidase (AGIs)	Glyset , Precose
3%	Amylin analogues	Symlin
3%	Meglitinides	- Prandin, Starlix

Bugu da ƙari, 5% na masu amsa suna shan wasu magunguna waɗanda ba a lissafa a sama ba, kuma 31% ba sa shan magungunan ciwon sukari kwata-kwata.

Sashin insulin na dogon lokaci shine nau'in insulin gama gari tsakanin masu binciken mu

Kashi na masu yin binciken	Nau'in insulin	Misalan insulin-sunan-iri
14%	Insulin mai dogon lokaci	Toujeo , Lantus , Levemir , Tresiba , Basaglar
8%	Rashin insulin mai gajeren aiki	Humulin R, Humulin R U-500 , Novolin R , Novolin ReliOn R
8%	Insulin mai saurin aiki	Novolog , Fita , Apidra, Humalog U-100, Humalog U-200, Admelog
7%	Cikakken insulin	Humalog 50/50, Humalog 75/25, Novolog 70/30 , Humulin 70/30, Novolin 70/30
6%	Matsakaici-aiki insulin	Humulin N, Novolin N , Novolin ReliOn N
4%	Saurin inhalation foda	Afrezz
4%	Hadin insulin	Xultophy , Soliqua

Bugu da ƙari, 2% na masu ba da amsa suna shan wani insulin da ba a lissafa a sama ba.

Dangantaka: Metformin sakamako masu illa

Yin fitsari akai-akai, gajiya, da kuma alamun GI sune rahotanni mafi yawan illolin magunguna masu magunguna ko insulin

• 24% sun ruwaito yawan fitsari.
  • Yin fitsari akai-akai yana shafar mata da suka amsa (30%) fiye da mata (18%).
  • Yin fitsari akai-akai yana shafar mafi yawan waɗanda suka amsa shekarunsu na 65 zuwa sama (31%) fiye da sauran rukunin shekarun.
• 24% sun ruwaito gajiya.
• 21% sun ruwaito sakamakon illa na GI (ciwon ciki, gas, gudawa, tashin zuciya, amai).
  • Hanyoyin cutar GI sun fi shafar mata da yawa (26%) fiye da maza (17%).
  • Hanyoyin cutar GI sun fi shafar mafi yawan masu amsawa daga shekaru 45 zuwa 54 (30%) fiye da sauran rukunin shekaru.
• 11% sun ruwaito rashin ci.
  • Rashin ci abinci yana shafar mafi yawan maza masu amsa (14%) fiye da mata (8%).
  • Rashin ci abinci yana shafar mafi yawan waɗanda aka ba da amsa daga shekara 25 zuwa 34 (19%) da 35 zuwa 44 (15%) fiye da sauran rukunin shekarun.
• 11% ya ruwaito asarar nauyi.
  • Rage nauyi ya fi shafar maza (14%) fiye da mata (8%).
  • Rage nauyi yana shafar mafi yawan waɗanda aka ba da amsa mai shekara 25 zuwa 34 (19%) da 35 zuwa 44 (15%) fiye da sauran rukunin shekarun.
  • 24% na masu amsa waɗanda suka ba da rahoton tsarin kula da ciwon sukari ya ba su damar rayuwa mafi ƙoshin lafiya kuma 18% waɗanda suka bayar da rahoton cewa suna motsa jiki kuma sun ba da rahoton asarar nauyi a matsayin sakamako mai illa.
• 11% sun ruwaito rashin ƙarfi na numfashi.
  • Breatharancin numfashi yana shafar mafi yawan waɗanda aka amsa masu shekaru 65 zuwa sama (12%) fiye da sauran rukunin shekaru.
• 10% sun ruwaito fitsari mai duhu.
• 8% sun ruwaito cututtukan yisti.
  • Yisti kamuwa da cutar ya shafi mafi yawan mata masu amsa (10%) fiye da maza (6%).
  • Yisti kamuwa da cutar ya shafi mafi yawan masu amsawa shekaru 25 zuwa 34 (15%) fiye da sauran kungiyoyin shekaru.
• 8% sun ruwaito rashin karfin jini.
  • Pressureananan hawan jini yana shafar mafi yawan waɗanda aka karɓa a cikin shekaru 25 zuwa 34 (15%) da 35 zuwa 44 (15%) fiye da sauran rukunin shekarun.
• 8% sun ba da rahoton wasu illolin (ƙimar nauyi da haɗin gwiwa da ƙashin ƙashi) ko babu wani illa a ciki kwata-kwata.
• 6% sun ba da rahoton mummunan kumburi
  • Tsananin kumburi yana shafar mafi yawan waɗanda aka ba da amsa mai shekara 55 zuwa 64 (3%) fiye da sauran rukunin shekarun.
• 1% ya ruwaito lactic acidosis.
• 31% sun ruwaito ba sa shan magungunan ciwon sukari ko insulin.

Raunin da aka ruwaito na magungunan ciwon sukari game da insulin ya bambanta

Daga waɗanda ke shan magani:

• 34% sun ruwaito tasirin GI
• 35% sun ruwaito yawan fitsari
• 32% sun ruwaito gajiya
• 15% sun ruwaito rashin ƙarfi na numfashi
• 8% sun ruwaito cututtukan yisti
• 5% sun bayar da rahoton rashin karfin jini

Daga waɗanda ke shan insulin:

• 41% sun ruwaito tasirin GI
• 27% sun ruwaito rashin ci
• 18% sun ruwaito fitsari mai duhu

54% na masu amsa suna biya daga aljihunsu don kula da ciwon sukari

A cewar Diungiyar Ciwon Suga ta Amurka (ADA) , 67.3% na likitancin da ke da alaƙa da ciwon sukari (gwajin glucose na jini, magani, kayayyaki, ziyara ga masu samar da lafiya, da sauransu) an rufe su ta Medicare, Medicaid, ko sojoji; 30.7% an rufe shi ta inshora mai zaman kansa; kuma kawai 2% na farashin ana biyan inshorar. Sakamakon bincikenmu ya ba da labarin irin wannan.

• 26% sun bayar da rahoton cewa inshora ya shafi duk kulawar su na ciwon sukari
• 20% sun ruwaito cewa Medicare ko Medicaid sun rufe duk kulawar su na ciwon sukari
• 16% sun bayar da rahoton cewa inshora wani ɓangare yana rufe kulawa da ciwon sukari
• 10% sun bayar da rahoton cewa Medicare ko Medicaid wani ɓangare suna rufe kulawa da ciwon sukari
• 4% sun ba da rahoton cewa suna biyan kuɗi daga aljihu tare da katin ragi na rangwame (SingleCare, GoodRx, RxSaver, da sauransu) don kula da ciwon sukari
• 3% sun bayar da rahoton cewa suna biyan kuɗi daga aljihunsu don duk kulawar su na ciwon sukari
• 21% sun bayar da rahoton cewa ba su da wani kulawa da ciwon sukari

Dangantaka: Nawa ne kudin insulin?

Hanyarmu:

SingleCare ta gudanar da wannan binciken na ciwon sukari ta yanar gizo ta hanyar AYTM a ranar 3 ga Oktoba, 2020. Wannan bayanan binciken ya haɗa da manya 500 na Amurka masu shekaru 18 + waɗanda aka ruwaito suna da ko ciwon suga. An raba jinsi 50/50.